THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE
THE PHARMACOLOGICAL DEVELOPMENT OF IPW-5371 FUMARATE AS A RADIATION MEDICAL COUNTERMEASURE FOR THE TREATMENT OF DELAYED RADIATION LUNG INJURY UNDER THE FDA ANIMAL RULE
IPW-5371 富马酸盐作为放射医学对策的药理学开发，用于治疗 FDA 动物规则下的迟发性辐射肺损伤
批准号：
10932585
负责人：
BARRY HART
金额：
$149.99万
依托单位：
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
项目状态：
已结题
起止时间：
2023-07-01 至 2024-06-30
关键词：
AcuteAnimal ModelAnimalsBiological MarkersCharacteristicsCritical PathwaysDevelopmentEvaluationFumaratesHistologicLungOrganPathway interactionsPreparationRadiationRadiation exposureRadiation induced damageToxicologyTransforming Growth Factor betaanimal ruleinnovationirradiationkinase inhibitormedical countermeasuremultiorgan injurypharmacokinetics and pharmacodynamicspharmacologicradiation-induced lung injuryradiological imagingreceptorsmall molecule
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This proposal, using partial body irradiation (PBI) animal models to study the delayed effects of acute radiation exposure (DEARE) on survival due to multi-organ injury, including the lungs. The proposal is focused on supporting the critical path for FDA approval of an Innovation Pathways, small molecule TGFβ Receptor-1 kinase inhibitor MCM. Under the guidance criteria of the FDA “Animal Rule” (AR).
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE
-
批准号：10661478
-
项目类别：
-
资助金额：$11.38万
-
财政年份：2020
-
负责人：BARRY HART
-
依托单位：
ACUTE RADIATION-INDUCED LUNG INJURY IN THE RHESUS MACAQUE AND ITS' TREATMENT BYIPW-5371, A SMALL MOLECULE INHIBITOR OF TGF# RECEPTOR-1 KINASE
-
批准号：9915646
-
项目类别：
-
资助金额：$231.56万
-
财政年份：2019
-
负责人：BARRY HART
-
依托单位：
海外基金
